Bioceres Crop Solutions Corp.

hello everyone and welcome to today's call titled biosphere's co-op solutions fiscal first quarter 2024 financial and operational results my name is ellen and i'll be the call operator today all participant lines will be muted throughout the presentation but at the end of the presentation there'll be an opportunity to ask a question if you'd like to ask a question at this time please press star followed by one your telephone keypad if at any point your question has been answered or you change your mind and would like to revoke your question please press star followed by two on your telephone keypad. I would now like to turn the call over to Paola Cervantes, Head of Investor Relations, to begin. Paola, please go ahead whenever you're ready.

Thank you and good morning to everyone joining us for today's call. The presentation today will be led by our Chief Executive Officer, Federico Trucco, and our Chief Financial Officer, Enrique Lopez-Lecube. Both of them will be available for the Q&A session following the presentation. Before we proceed, I would like to make the following safe harbor statement. Today's call will contain forward-looking statements, and I refer you to the forward-looking statements section of the earnings release and presentation, as well as the recent filings with the SEC. We assume no obligation to update or revise any forward-looking statements to reflect new or odd change circumstances. This conference call is being webcast, and the webcast link is available at Biocera's Crop Solutions Investor Relations website. At this time, I will turn the call over to our CEO, Federico Trucco. Thank you.

Thank you, Paula, and good morning, everyone. Thanks for joining us today in our first quarter of fiscal 2024 earnings call. Please turn to slide three for the main business and financial highlights for this period. Our first quarter of last year was a record-setting quarter in which we nearly doubled our revenues when compared to the year before period, that is, the first quarter of fiscal 22. Part of last year's growth resulted from anticipated second quarter sales, as weather conditions were quickly deteriorating in our main Latin market. In retrospect, this early move allowed us to mitigate part of the effects of what turned out to be a historical drought extending through the next three quarters. We are now happy to say that rains have finally normalized and that planting in our main markets are progressing at full force. Our first quarter's financial performance is starting to reflect this regained momentum, with total revenues at $116.6 million, with most segments exhibiting post-drought recovery and the international business continuing to expand. Adjusted EBITDA for the quarter was $16.3 million. Enrique will explain our financial performance in greater detail in his analysis. On the HB4 front, Weed harvest has started in Northern Argentina with very favorable results for HB4 materials in an otherwise poor season for the crop. Soy plantings are advancing well with good moisture conditions in our targeted regions. Our Generation HB4 program is currently running at 150% of prior season acreage with an important 6x increase in Brazil. An important milestone in this quarter was the granting of our first patent covering our ultra high concentrate or UHC technology by the USPTO. This technology sets the new gold standard in biological nitrogen fixation for legumes, consolidating our leadership position in this important seed treatment category. We'll provide an overview of this milestone and other groundbreaking improvements in seed applied technologies that clearly position us as the technology leaders within this segment of biological ag inputs. And finally, we have completed the construction of our new state-of-the-art adjuvant production plant in Londrina, Brazil. strategically positioned to expand our footprint in the high growth Brazilian market as of this year. Let's turn now to the next slide to put our current quarter into historical perspective. As I indicated before, we're comparing to a record high quarter the year before. and also achieving our second highest historical revenue mark as we do so, while continuing on the upward momentum exhibited in our last quarter of fiscal 23. I don't think there's much more to add to these slides, so I'll pass it on to Enrique so that he can give you a more complete overview of our financial performance. Kike?